We are live on ! Find out more
Aberdeen Group

Aberdeen Group Portfolio holdings

AUM $61.9B
1-Year Est. Return 29.81%
This Fund
S&P 500
This Quarter Est. Return
+13.55%
1 Year Est. Return
+29.81%
3 Year Est. Return
+93.17%
5 Year Est. Return
+119.65%
10 Year Est. Return
AUM
$58.8B
AUM Growth
+$7.51B
Cap. Flow
+$1.9B
Cap. Flow %
3.23%
Top 10 Hldgs %
34.73%
Holding
979
New
37
Increased
681
Reduced
201
Closed
28

Sector Composition

1 Technology 32.3%
2 Healthcare 12.75%
3 Consumer Discretionary 11.56%
4 Financials 10.82%
5 Communication Services 9.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KRRO icon
826
Korro Bio
KRRO
$177M
$1.05M ﹤0.01%
84,428
MTCH icon
827
Match Group
MTCH
$9.17B
$1.05M ﹤0.01%
33,990
+14,314
+73% +$428K
HIW icon
828
Highwoods Properties
HIW
$3.67B
$1.05M ﹤0.01%
33,650
+3,727
+12% +$110K
PYXS icon
829
Pyxis Oncology
PYXS
$144M
$1M ﹤0.01%
913,045
JD icon
830
JD.com
JD
$40.2B
$1M ﹤0.01%
30,722
+8,180
+36% +$279K
ALLO icon
831
Allogene Therapeutics
ALLO
$625M
$980K ﹤0.01%
867,250
MOS icon
832
The Mosaic Company
MOS
$7.1B
$970K ﹤0.01%
26,579
+1,104
+4% +$35.4K
GNL icon
833
Global Net Lease
GNL
$1.94B
$968K ﹤0.01%
129,182
+31,589
+32% +$240K
CDP icon
834
COPT Defense Properties
CDP
$4.27B
$949K ﹤0.01%
34,396
-6,879
-17% -$186K
BNL icon
835
Broadstone Net Lease
BNL
$4.36B
$924K ﹤0.01%
57,564
+6,618
+13% +$106K
LINE
836
Lineage Inc
LINE
$10.1B
$922K ﹤0.01%
21,178
+4,610
+28% +$223K
IOVA icon
837
Iovance Biotherapeutics
IOVA
$2.22B
$888K ﹤0.01%
516,289
+384,489
+292% +$957K
CSIQ icon
838
Canadian Solar
CSIQ
$1.02B
$885K ﹤0.01%
80,130
-17,015
-18% -$165K
ORKA
839
Oruka Therapeutics
ORKA
$5.44B
$879K ﹤0.01%
+78,380
New +$817K
ACM icon
840
Aecom
ACM
$8.72B
$878K ﹤0.01%
7,783
+3,054
+65% +$317K
ITRI icon
841
Itron
ITRI
$3.79B
$877K ﹤0.01%
6,665
WIX icon
842
WIX.com
WIX
$2.17B
$791K ﹤0.01%
4,991
+993
+25% +$160K
LXP icon
843
LXP Industrial Trust
LXP
$3.43B
$786K ﹤0.01%
19,032
+2,023
+12% +$83.2K
APLE icon
844
Apple Hospitality REIT
APLE
$3.95B
$778K ﹤0.01%
66,660
-14,009
-17% -$164K
CRL icon
845
Charles River Laboratories
CRL
$10.8B
$778K ﹤0.01%
5,127
+1,586
+45% +$211K
FCPT icon
846
Four Corners Property Trust
FCPT
$2.89B
$776K ﹤0.01%
28,852
+3,323
+13% +$91.5K
WLK icon
847
Westlake Corp
WLK
$9.97B
$767K ﹤0.01%
10,098
+97
+1% +$7.94K
AGRO icon
848
Adecoagro
AGRO
$1.45B
$766K ﹤0.01%
83,776
-10,863
-11% -$106K
NDSN icon
849
Nordson
NDSN
$16.3B
$764K ﹤0.01%
3,562
-424
-11% -$84.4K
DEI icon
850
Douglas Emmett
DEI
$2.09B
$763K ﹤0.01%
50,716
+5,871
+13% +$84.8K

Similar funds

Aberdeen Group's Q2 2025 Portfolio in Review

As of Q2 2025, Aberdeen Group held 979 positions worth $58.8B, up 15% from $51.3B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Aberdeen Group deployed $1.9B of net new capital in Q2 2025, opening 37 new positions and adding to 681 existing holdings. Its largest new stake was On Holding: 756,875 shares worth $39.4M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Southern Copper, an estimated $61.4M trimmed.

  • Aberdeen Group's largest Q2 2025 buy was On Holding: 756,875 shares worth $39.4M.
  • Aberdeen Group added most to Apple in Q2 2025, an estimated $154M increase.
  • Aberdeen Group's biggest Q2 2025 reduction was Southern Copper, cutting an estimated $61.4M.
  • Aberdeen Group fully exited Globant in Q2 2025, selling an estimated $60.5M.
  • Aberdeen Group's ten largest holdings make up 35% of its $58.8B portfolio in Q2 2025.
  • Aberdeen Group opened 37 new positions and closed 28 in Q2 2025.
  • Aberdeen Group's portfolio value rose 15% quarter-over-quarter to $58.8B.

Based on Aberdeen Group's 13F filing for Q2 2025, filed 24 Jul 2025.